These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15741187)

  • 1. Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity.
    Hou MH; Wang AH
    Nucleic Acids Res; 2005; 33(4):1352-61. PubMed ID: 15741187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the DNA-interacting properties and anticancer activity of a Ni(II)-coordinated mithramycin dimer complex.
    Hsu CW; Kuo CF; Chuang SM; Hou MH
    Biometals; 2013 Feb; 26(1):1-12. PubMed ID: 23097078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of polyamines on the DNA-reactive properties of dimeric mithramycin complexed with cobalt(II): implications for anticancer therapy.
    Hou MH; Lu WJ; Huang CY; Fan RJ; Yuann JM
    Biochemistry; 2009 Jun; 48(22):4691-8. PubMed ID: 19368394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of sequence-specific DNA binding, DNA cleavage, and topoisomerase I inhibition by the dimeric chromomycin A3 complexed with Fe(II).
    Hou MH; Lu WJ; Lin HY; Yuann JM
    Biochemistry; 2008 May; 47(20):5493-502. PubMed ID: 18426223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3.
    Hsu CW; Chuang SM; Wu WL; Hou MH
    PLoS One; 2012; 7(9):e43792. PubMed ID: 22984445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of spermine competition on the efficacy of DNA-binding Fe(II), Co(II), and Cu(II) complexes of dimeric chromomycin A(3).
    Lu WJ; Wang HM; Yuann JM; Huang CY; Hou MH
    J Inorg Biochem; 2009 Dec; 103(12):1626-33. PubMed ID: 19800127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biostructural chemistry of magnesium. regulation of mithramycin-DNA interactions by Mg2+ coordination.
    Huang HW; Li D; Cowan JA
    Biochimie; 1995; 77(9):729-38. PubMed ID: 8789464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences.
    Barceló F; Scotta C; Ortiz-Lombardía M; Méndez C; Salas JA; Portugal J
    Nucleic Acids Res; 2007; 35(7):2215-26. PubMed ID: 17369273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of (MTR)2Zn2+ complex to chromatin: a comparison with (MTR)2Mg2+ complex.
    Das S; Dasgupta D
    J Inorg Biochem; 2005 Mar; 99(3):707-15. PubMed ID: 15708791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model.
    Choi ES; Jung JY; Lee JS; Park JH; Cho NP; Cho SD
    Cancer Lett; 2013 Jan; 328(1):65-72. PubMed ID: 23000424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of mithramycin with DNA. Evidence that mithramycin binds to DNA as a dimer in a right-handed screw conformation.
    Demicheli C; Albertini JP; Garnier-Suillerot A
    Eur J Biochem; 1991 Jun; 198(2):333-8. PubMed ID: 1828228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of antitumor antibiotic Mithramycin with Mn2+ and the potential cellular targets of Mithramycin after association with Mn2+.
    Dutta S; Lahiri S; Banerjee A; Saha S; Dasgupta D
    J Biomol Struct Dyn; 2015; 33(2):434-46. PubMed ID: 24559512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel trihydroxamate-containing peptides: design, synthesis, and metal coordination.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2006; 84(5):472-89. PubMed ID: 16705688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of aureolic acid antibiotic, chromomycin A3 with Cu2+ and its negative effect upon DNA binding property of the antibiotic.
    Lahiri S; Takao T; Devi PG; Ghosh S; Ghosh A; Dasgupta A; Dasgupta D
    Biometals; 2012 Apr; 25(2):435-50. PubMed ID: 22205111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mithramycin: a very strong metal chelating agent.
    Demicheli C; Garnier-Suillerot A
    Biochim Biophys Acta; 1993 Aug; 1158(1):59-64. PubMed ID: 8353132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fe- and Co-bleomycins bound to site specific and nonspecific DNA decamers: comparative binding and reactivity of their metal centers.
    Fulmer P; Zhao C; Li W; DeRose E; Antholine WE; Petering DH
    Biochemistry; 1997 Apr; 36(14):4367-74. PubMed ID: 9100034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mithramycin cannot bind to left-handed poly(dG-m5dC) in the presence of Mg2+ ion.
    Demicheli C; Garnier-Suillerot A
    Biochem Biophys Res Commun; 1991 May; 177(1):511-7. PubMed ID: 1828342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antitumor antibiotics, mithramycin and chromomycin, with Zn(II).
    Devi PG; Pal S; Banerjee R; Dasgupta D
    J Inorg Biochem; 2007 Jan; 101(1):127-37. PubMed ID: 17070920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
    Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
    Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of iron(III)-anthracycline complexes.
    Fiallo MM; Drechsel H; Garnier-Suillerot A; Matzanke BF; Kozlowski H
    J Med Chem; 1999 Jul; 42(15):2844-51. PubMed ID: 10425093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.